Cargando…
Proteolytic Processing of Stat6 Signaling in Mast Cells as a Negative Regulatory Mechanism
Accumulating evidence has shown the importance of Stat6-mediated signaling in allergic diseases. In this study, we show a novel regulatory mechanism of Stat6-mediated signaling in mast cells. When Stat6 is activated by interleukin (IL)-4 and translocated to the nucleus, Stat6 is cleaved by a nucleus...
Autores principales: | Suzuki, Kotaro, Nakajima, Hiroshi, Kagami, Shin-ichiro, Suto, Akira, Ikeda, Kei, Hirose, Koichi, Hiwasa, Takaki, Takeda, Kiyoshi, Saito, Yasushi, Akira, Shizuo, Iwamoto, Itsuo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194019/ https://www.ncbi.nlm.nih.gov/pubmed/12093868 http://dx.doi.org/10.1084/jem.20011682 |
Ejemplares similares
-
IL-4–Stat6 Signaling Induces Tristetraprolin Expression and Inhibits TNF-α Production in Mast Cells
por: Suzuki, Kotaro, et al.
Publicado: (2003) -
Development and characterization of IL-21–producing CD4(+) T cells
por: Suto, Akira, et al.
Publicado: (2008) -
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3
por: Tanaka, Shigeru, et al.
Publicado: (2014) -
TAp63, a methotrexate target in CD4(+) T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis
por: Suga, Kensuke, et al.
Publicado: (2023) -
Sox12 promotes T reg differentiation in the periphery during colitis
por: Tanaka, Shigeru, et al.
Publicado: (2018)